Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inovio Pharma (NQ: INO )

0.9461 -0.0086 (-0.90%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,675,377
Open 0.9660
Bid (Size) 0.9600 (20)
Ask (Size) 0.9645 (11)
Prev. Close 0.9547
Today's Range 0.9329 - 0.9990
52wk Range 0.9463 - 4.000
Shares Outstanding 210,356,896
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're starting the final day of the week with a breakdown of the biggest pre-market stock movers worth watching on Friday! 
Via InvestorPlace
Inovio Pharmaceuticals (INO) Q4 2022 Earnings Call Transcript
INO earnings call for the period ending December 31, 2022. 
Via The Motley Fool

Performance

YTD
-37.76%
-37.76%
1 Month
-32.90%
-32.90%
3 Month
-43.35%
-43.35%
6 Month
-47.73%
-47.73%
1 Year
-74.77%
-74.77%

More News

Read More
Why Inovio (INO) Shares Are Moving After-Hours
Via Benzinga
Earnings Scheduled For March 1, 2023
Via Benzinga
2 Stocks to Sell or Remove From Your Watchlist in 2023
Via The Motley Fool
Inovio Pharmaceuticals (INO) Q3 2022 Earnings Call Transcript
Via The Motley Fool
Coronavirus Vaccine Market To Surpass $95 Billion By 2028
Via FinancialNewsMedia
Exposures COVID-19
Inovio Pharma Releases Favorable Data From Booster DNA Vaccine Candidate For Ebola
Via Benzinga
3 Sorry Pharma Stocks to Sell in February Before It’s Too Late
Via InvestorPlace
INOVIO Announces Further Reorganization, Continues Focus on Promising DNA Candidates
Via Benzinga
If You Invested $1,000 In Inovio Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now
Via Benzinga
Futu Holdings, UP Fintech Holding And Some Other Big Stocks Moving Lower On Friday
Via Benzinga
Micron, Lexicon Pharmaceuticals And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Via Benzinga
Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket
Via Benzinga
Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket
Via Benzinga
Within A Month After Pulling Plug On COVID-19 Booster Study, Inovio Shelves Two More Infectious Disease Programs
Via Benzinga
3 Stocks to Avoid Right Now
Via The Motley Fool
While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants
Via FinancialNewsMedia
Exposures COVID-19
Why Inovio Pharmaceuticals Stock Is Popping Off
Via Benzinga
What's Going On With Inovio Pharmaceuticals Stock Tuesday After Hours
Via Benzinga
Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa
Via Benzinga
Why Inovio Pharmaceuticals Stock Zoomed Nearly 6% Higher Today
Via The Motley Fool
Inovio Pharma Stops Work On INO-4800 As COVID-19 Heterologous Booster
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
Via Benzinga
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.